BCL6 and diffuse large B-cell lymphoma: In this context, our study found that ABT‐199/Apatinib was also effective on OCI‐Ly1, OCI‐Ly3 and OCI‐Ly10 cell lines from activated B‐cell‐like (ABC) which expression of BCL‐6, CD10, and MUM1, as well as primary DLBCL blasts from patients [46].